14hon MSN
Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs?
Over the past two years, Merck (NYSE: MRK) has faced several challenges, resulting in a decline in the company's share price.
President Donald Trump's $2,000 "dividend" plan only works, economists say, if there's enough tariff revenue to cover them.
There’s talk of a reconciliation bill that may offer “tariff dividends,” health-account payments, and other goodies — right ...
Headlines about the U.S. job market haven’t exactly been encouraging in 2025. Wage growth has cooled, big-tech layoffs keep ...
In its most recent quarter, which ended Sept. 27, Kraft Heinz's earnings per share totaled $0.52, which exceeded the rate of ...
The report from Clearwater shows that corporates choosing a dynamic cash allocation strategy have earned an average annual ...
PepsiCo’s dividend faces risks from mounting debt and weak cash flow. Discover why a dividend cut may loom and why investors ...
These cheap dividend stocks would make great cornerstone pieces to any portfolio -- especially for investors looking for a ...
Opinion
Trump’s $2,000 tariff dividend may be a smart political move. But it would be a huge economic gamble
One of the only things that polls worse than the Trump economy is the president’s almost unprecedented use of tariffs.
President Trump says the government will distribute checks to Americans from tariff revenue. Here's what that could mean.
President Trump’s proposal to use tariff revenue to pay individuals “at least” $2,000 is facing legal and logistical roadblocks, as well as skepticism from some on the right. Trump has floated ...
For as long as many of us can remember, the very best method for understanding how much you can or should spend during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results